Herein we report an asphyctic preterm neonate with respiratory distress and prothrombotic risk factors that responded positively to rtPA treatment following 2 attacks of acute thrombosis.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Herein we report an asphyctic preterm neonate with respiratory distress and prothrombotic risk factors that responded positively to rtPA treatment following 2 attacks of acute thrombosis.
📊
Key Findings & Data:Herein we report an asphyctic preterm neonate with respiratory distress and prothrombotic risk factors that responded positively to rtPA treatment following 2 attacks of acute thrombosis.
💡
Conclusion & Impact:Herein we report an asphyctic preterm neonate with respiratory distress and prothrombotic risk factors that responded positively to rtPA treatment following 2 attacks of acute thrombosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Herein we report an asphyctic preterm neonate with respiratory distress and prothrombotic risk factors that responded positively to rtPA treatment following 2 attacks of acute thrombosis.
Özet
Bu yazıda solunum sıkıntısı ve asfiksi ile doğmuş, protrombotik risk faktörleri de olan bir prematüre bebekte iki tromboz atağının rekombinant doku plazminojen aktivatörü ile başarılı bir şekilde tedavi edildiği sunulmuş, ilacın etkinliği ve bu grup hastalarda dahi uygulanılabilirliği vurgulanmıştır.
🔖
Cite This Article
ERDİNÇ, K., SARICI, S. Ü., DABAK, O., GÜRSEL, O., GÜLER, A., KÜREKÇİ, A. E., CANPOLAT, F. E. (2013). Rekombinan doku plazminojen aktivatörü ile başarılı bir şekilde tedavi edilmiş bir neonatal tromboz olgusu. Turkish Journal of Hematology, Cilt: 30 - Sayı: 3, 325–327. https://ajindex.com/articles/413135
Nowak-Göttl U, Kosch A, Schlegel N. Neonatal thromboembolism. Semin Thromb Hemost 2003;29:227- 234
Nakashima T, Minematsu K. Prospects of thrombolytic therapy for acute ischemic stroke. Brain Nerve 2009;61:1003-1012
Aschermann M, Horák J, Reznícek V, Blohlávek J, Aschermann O. Fibrinolytic therapy in acute myocardial infarct. Cas Lek Cesk 2003;142:582-585
Klinge J, Hofbeck M, Ries M, Schaf J, Singer H, von der Emde J. Thrombolysis of modified Blalock-Taussig shunts in childhood with recombinant tissue-type plasminogen activator. Z Kardiol 1995;84:476-480
Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 2001;119(Suppl 1):344-370S
Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;96:939-943
Raffini L. Thrombolysis for intravascular thrombosis in neonates and children. Curr Opin Pediatr 2009;21:9-14
Hartmann J, Hussein A, Trowitzsch E, Becker J, Hennecke KH. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed 2001;85:18-22
Torres-Valdivieso MJ, Cobas J, Barrio C, Muñoz C, Pascual M, Orbea C, Rodriguez E, Gutiérrez F Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant. Am J Perinatol 2003;20:91- 96
Khan JU, Takemoto CM, Casella JF Streiff MB, Nwankwo IJ, Kim HS. Catheter-directed thrombolysis of inferior vena cava thrombosis in a 13-day-old neonate and review of literature. Cardiovasc Intervent Radiol 2008;31(Suppl 2):153-160
Knöfler R, Dinger J, Kabus M, Müller D, Lauterbach I, Rupprecht E, Taut-Sack H, Weissbach G. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator. Semin Thromb Hemost 2001;27:169-174
Grieg A. Thrombolysis of a neonatal brachial artery thrombosis with tissue plasminogen activator. J Perinatol 1998;18:460-462
Manco-Johnson M, Nuss R. Neonatal thrombotic disorders. Neoreviews 2000;10:201-204
Anderson B, Urs P, Tudehope D, Ward C. The use of recombinant tissue plasminogen activator in the management of infective intracardiac thrombi in pre-term infants with thrombocytopaenia. J Paediatr Child Health 2009;45:598-601.